Diabetes mellitus Samples

Central BioHub offers human serum samples from patients with Diabetes mellitus like Type 2 diabetes mellitus or Unspecified diabetes mellitus. You can use the filter functions to specify your desired products by laboratory parameters and donor specifications like ethnicity, BMI, medication, age and gender. Procurement takes place from consented donors under strict ethical standards. For normal control groups please switch to the category Healthy Donors. If you do not find the research samples you are looking for, please contact us.

Available filters
-
-
816 Products

Human Serum - Cross-reactive carbohydrate determina... - E11.90 - Self-reported Healthy

Donor:
Gender: Female Age: 50 Ethnic group: European/Caucasian
Diagnosed disease:
E11.90
Medication:
L-thyroxine
Parameter:
Cross-reactive carbohydrate determinants (CCD) Hematokrit Hemoglobin (Hb) SIgE Italian/Mediterranean/Funeral cypress (t23) SIgE Almond (f20) SIgE Alternaria alternata (m6) SIgE Apple (f49) SIgE Apricot (f237) SIgE Aspergillus fumigatus (m3) SIgE Beef (f27) ...
Donor:
Gender:
Female
Age:
50 Years
Ethnic group:
European/Caucasian
BMI:
52 kg/m²
Blood type:
B
Rhesus factor:
not specified
Weight:
160 kg
Height:
175 cm
Sample:
Matrix:
Serum
Condition:
perfect
Freeze-Thaw-Cycle:
0
Diseases:
  • E11.90
Medication:
  • L-thyroxine (Dosages: 100not specified)
  • Rocaltrol (Dosages: 50not specified)
  • Victoza
  • calcium (Dosages: 500not specified)
  • metformin
  • none
  • risedronic acid
Parameter Result Ref. / Cut-Off Measuring Information
Cross-reactive carbohydrate determinants (CCD)
Qual:
Quant: < 0.35 kU/L
Source: this donation
< 0.35 kU/L
Method: Immunoblot
System: EUROLineScan-Programm EUROIMMUN AG
Hematokrit
Qual:
Quant: 39.00 %
Source: this donation
not specified not specified
Method: not specified
System: not specified not specified
Hemoglobin (Hb)
Qual:
Quant: 13.20 g/dl
Source: this donation
not specified not specified
Method: not specified
System: not specified not specified
SIgE Italian/Mediterranean/Funeral cypress (t23)
Qual:
Quant: < 0.35 kU/L
Source: this donation
Remarks: CAP/RAST/EAST-class:0
< 0.35 kU/L
Method: Immunoblot
System: EUROLineScan-Programm EUROIMMUN AG
SIgE Almond (f20)
Qual:
Quant: < 0.35 kU/L
Source: this donation
Remarks: CAP/RAST/EAST-class:0
< 0.35 kU/L
Method: Immunoblot
System: EUROLineScan-Programm EUROIMMUN AG
SIgE Alternaria alternata (m6)
Qual:
Quant: < 0.35 kU/L
Source: this donation
Remarks: CAP/RAST/EAST-class:0
< 0.35 kU/L
Method: Immunoblot
System: EUROLineScan-Programm EUROIMMUN AG
SIgE Apple (f49)
Qual:
Quant: 1.70 kU/L
Source: this donation
Remarks: CAP/RAST/EAST-class:2
< 0.35 kU/L
Method: Immunoblot
System: EUROLineScan-Programm EUROIMMUN AG
SIgE Apricot (f237)
Qual:
Quant: < 0.35 kU/L
Source: this donation
Remarks: CAP/RAST/EAST-class:0
< 0.35 kU/L
Method: Immunoblot
System: EUROLineScan-Programm EUROIMMUN AG
SIgE Aspergillus fumigatus (m3)
Qual:
Quant: < 0.35 kU/L
Source: this donation
Remarks: CAP/RAST/EAST-class:0
< 0.35 kU/L
Method: Immunoblot
System: EUROLineScan-Programm EUROIMMUN AG
SIgE Beef (f27)
Qual:
Quant: < 0.35 kU/L
Source: this donation
Remarks: CAP/RAST/EAST-class:0
< 0.35 kU/L
Method: Immunoblot
System: EUROLineScan-Programm EUROIMMUN AG
SIgE Birch (t3)
Qual:
Quant: 33.00 kU/L
Source: this donation
Remarks: CAP/RAST/EAST-class:4
< 0.35 kU/L
Method: Immunoblot
System: EUROLineScan-Programm EUROIMMUN AG
SIgE Carrot (f31)
Qual:
Quant: 0.35 kU/L
Source: this donation
Remarks: CAP/RAST/EAST-class:1
< 0.35 kU/L
Method: Immunoblot
System: EUROLineScan-Programm EUROIMMUN AG
SIgE Cat dander (e1)
Qual:
Quant: < 0.35 kU/L
Source: this donation
Remarks: CAP/RAST/EAST-class:0
< 0.35 kU/L
Method: Immunoblot
System: EUROLineScan-Programm EUROIMMUN AG
SIgE Celery (f85)
Qual:
Quant: < 0.35 kU/L
Source: this donation
Remarks: CAP/RAST/EAST-class:0
< 0.35 kU/L
Method: Immunoblot
System: EUROLineScan-Programm EUROIMMUN AG
SIgE Cladosporium herbarum (m2)
Qual:
Quant: < 0.35 kU/L
Source: this donation
Remarks: CAP/RAST/EAST-class:0
< 0.35 kU/L
Method: Immunoblot
System: EUROLineScan-Programm EUROIMMUN AG
SIgE Cockroach, German (i6)
Qual:
Quant: < 0.35 kU/L
Source: this donation
Remarks: CAP/RAST/EAST-class:0
< 0.35 kU/L
Method: Immunoblot
System: EUROLineScan-Programm EUROIMMUN AG
SIgE Cocksfoot (g3)
Qual:
Quant: < 0.35 kU/L
Source: this donation
Remarks: CAP/RAST/EAST-class:0
< 0.35 kU/L
Method: Immunoblot
System: EUROLineScan-Programm EUROIMMUN AG
SIgE Common ragweed (w1)
Qual:
Quant: < 0.35 kU/L
Source: this donation
Remarks: CAP/RAST/EAST-class:0
< 0.35 kU/L
Method: Immunoblot
System: EUROLineScan-Programm EUROIMMUN AG
SIgE Common wasp (Yellow jacket) (i3)
Qual:
Quant: < 0.35 kU/L
Source: this donation
Remarks: CAP/RAST/EAST-class:0
< 0.35 kU/L
Method: Immunoblot
System: EUROLineScan-Programm EUROIMMUN AG
SIgE Crab (f23)
Qual:
Quant: < 0.35 kU/L
Source: this donation
Remarks: CAP/RAST/EAST-class:0
< 0.35 kU/L
Method: Immunoblot
System: EUROLineScan-Programm EUROIMMUN AG
SIgE Cultivated rye (g12)
Qual:
Quant: < 0.35 kU/L
Source: this donation
Remarks: CAP/RAST/EAST-class:0
< 0.35 kU/L
Method: Immunoblot
System: EUROLineScan-Programm EUROIMMUN AG
SIgE Dermatophagoides farinae (d2)
Qual:
Quant: < 0.35 kU/L
Source: this donation
Remarks: CAP/RAST/EAST-class:0
< 0.35 kU/L
Method: Immunoblot
System: EUROLineScan-Programm EUROIMMUN AG
SIgE Dermatophagoides pteronyssinus (d1)
Qual:
Quant: < 0.35 kU/L
Source: this donation
Remarks: CAP/RAST/EAST-class:0
< 0.35 kU/L
Method: Immunoblot
System: EUROLineScan-Programm EUROIMMUN AG
SIgE Egg white (f1)
Qual:
Quant: < 0.35 kU/L
Source: this donation
Remarks: CAP/RAST/EAST-class:0
< 0.35 kU/L
Method: Immunoblot
System: EUROLineScan-Programm EUROIMMUN AG
SIgE Egg yolk (f75)
Qual:
Quant: < 0.35 kU/L
Source: this donation
Remarks: CAP/RAST/EAST-class:0
< 0.35 kU/L
Method: Immunoblot
System: EUROLineScan-Programm EUROIMMUN AG
SIgE Fish (cod) (f3)
Qual:
Quant: < 0.35 kU/L
Source: this donation
Remarks: CAP/RAST/EAST-class:0
< 0.35 kU/L
Method: Immunoblot
System: EUROLineScan-Programm EUROIMMUN AG
SIgE Greer Labs., Inc. (h1)
Qual:
Quant: 15.40 kU/L
Source: this donation
Remarks: CAP/RAST/EAST-class:3
< 0.35 kU/L
Method: Immunoblot
System: EUROLineScan-Programm EUROIMMUN AG
SIgE Grey alder (t2)
Qual:
Quant: 45.00 kU/L
Source: this donation
Remarks: CAP/RAST/EAST-class:4
< 0.35 kU/L
Method: Immunoblot
System: EUROLineScan-Programm EUROIMMUN AG
SIgE Hazel (t4)
Qual:
Quant: 10.50 kU/L
Source: this donation
Remarks: CAP/RAST/EAST-class:3
< 0.35 kU/L
Method: Immunoblot
System: EUROLineScan-Programm EUROIMMUN AG
SIgE Hazel nut (f17)
Qual:
Quant: 1.40 kU/L
Source: this donation
Remarks: CAP/RAST/EAST-class:2
< 0.35 kU/L
Method: Immunoblot
System: EUROLineScan-Programm EUROIMMUN AG
SIgE Honey bee (i1)
Qual:
Quant: < 0.35 kU/L
Source: this donation
Remarks: CAP/RAST/EAST-class:0
< 0.35 kU/L
Method: Immunoblot
System: EUROLineScan-Programm EUROIMMUN AG
SIgE Horse dander (e3)
Qual:
Quant: < 0.35 kU/L
Source: this donation
Remarks: CAP/RAST/EAST-class:0
< 0.35 kU/L
Method: Immunoblot
System: EUROLineScan-Programm EUROIMMUN AG
SIgE Kiwi (f84)
Qual:
Quant: < 0.35 kU/L
Source: this donation
Remarks: CAP/RAST/EAST-class:0
< 0.35 kU/L
Method: Immunoblot
System: EUROLineScan-Programm EUROIMMUN AG
SIgE Latex (k82)
Qual:
Quant: < 0.35 kU/L
Source: this donation
Remarks: CAP/RAST/EAST-class:0
< 0.35 kU/L
Method: Immunoblot
System: EUROLineScan-Programm EUROIMMUN AG
SIgE Milk (f2)
Qual:
Quant: < 0.35 kU/L
Source: this donation
Remarks: CAP/RAST/EAST-class:0
< 0.35 kU/L
Method: Immunoblot
System: EUROLineScan-Programm EUROIMMUN AG
SIgE Mugwort (w6)
Qual:
Quant: < 0.35 kU/L
Source: this donation
Remarks: CAP/RAST/EAST-class:0
< 0.35 kU/L
Method: Immunoblot
System: EUROLineScan-Programm EUROIMMUN AG
SIgE Mutton (f88)
Qual:
Quant: < 0.35 kU/L
Source: this donation
Remarks: CAP/RAST/EAST-class:0
< 0.35 kU/L
Method: Immunoblot
System: EUROLineScan-Programm EUROIMMUN AG
SIgE Oak (t7)
Qual:
Quant: 13.40 kU/L
Source: this donation
Remarks: CAP/RAST/EAST-class:3
< 0.35 kU/L
Method: Immunoblot
System: EUROLineScan-Programm EUROIMMUN AG
SIgE Peanut (f13)
Qual:
Quant: < 0.35 kU/L
Source: this donation
Remarks: CAP/RAST/EAST-class:0
< 0.35 kU/L
Method: Immunoblot
System: EUROLineScan-Programm EUROIMMUN AG
SIgE Penicillium chrysogenum (P. notatum) (m1)
Qual:
Quant: < 0.35 kU/L
Source: this donation
Remarks: CAP/RAST/EAST-class:0
< 0.35 kU/L
Method: Immunoblot
System: EUROLineScan-Programm EUROIMMUN AG
SIgE Plantain, Ribwort (w9)
Qual:
Quant: < 0.35 kU/L
Source: this donation
Remarks: CAP/RAST/EAST-class:0
< 0.35 kU/L
Method: Immunoblot
System: EUROLineScan-Programm EUROIMMUN AG
SIgE Potato (f35)
Qual:
Quant: < 0.35 kU/L
Source: this donation
Remarks: CAP/RAST/EAST-class:0
< 0.35 kU/L
Method: Immunoblot
System: EUROLineScan-Programm EUROIMMUN AG
SIgE Rice (f9)
Qual:
Quant: < 0.35 kU/L
Source: this donation
Remarks: CAP/RAST/EAST-class:0
< 0.35 kU/L
Method: Immunoblot
System: EUROLineScan-Programm EUROIMMUN AG
SIgE Rye (f5)
Qual:
Quant: < 0.35 kU/L
Source: this donation
Remarks: CAP/RAST/EAST-class:0
< 0.35 kU/L
Method: Immunoblot
System: EUROLineScan-Programm EUROIMMUN AG
SIgE Sesame seed (f10)
Qual:
Quant: < 0.35 kU/L
Source: this donation
Remarks: CAP/RAST/EAST-class:0
< 0.35 kU/L
Method: Immunoblot
System: EUROLineScan-Programm EUROIMMUN AG
SIgE Shrimp (f24)
Qual:
Quant: < 0.35 kU/L
Source: this donation
Remarks: CAP/RAST/EAST-class:0
< 0.35 kU/L
Method: Immunoblot
System: EUROLineScan-Programm EUROIMMUN AG
SIgE Soybean (f14)
Qual:
Quant: < 0.35 kU/L
Source: this donation
Remarks: CAP/RAST/EAST-class:0
< 0.35 kU/L
Method: Immunoblot
System: EUROLineScan-Programm EUROIMMUN AG
SIgE Sweet vernal grass (g1)
Qual:
Quant: < 0.35 kU/L
Source: this donation
Remarks: CAP/RAST/EAST-class:0
< 0.35 kU/L
Method: Immunoblot
System: EUROLineScan-Programm EUROIMMUN AG
SIgE Timothy grass (g6)
Qual:
Quant: < 0.35 kU/L
Source: this donation
Remarks: CAP/RAST/EAST-class:0
< 0.35 kU/L
Method: Immunoblot
System: EUROLineScan-Programm EUROIMMUN AG
SIgE Tomato (f25)
Qual:
Quant: < 0.35 kU/L
Source: this donation
Remarks: CAP/RAST/EAST-class:0
< 0.35 kU/L
Method: Immunoblot
System: EUROLineScan-Programm EUROIMMUN AG
SIgE Wheat flour (f4)
Qual:
Quant: < 0.35 kU/L
Source: this donation
Remarks: CAP/RAST/EAST-class:0
< 0.35 kU/L
Method: Immunoblot
System: EUROLineScan-Programm EUROIMMUN AG
SIgE Yeast (f45)
Qual:
Quant: < 0.35 kU/L
Source: this donation
Remarks: CAP/RAST/EAST-class:0
< 0.35 kU/L
Method: Immunoblot
System: EUROLineScan-Programm EUROIMMUN AG
SIgE dog (e2)
Qual:
Quant: < 0.35 kU/L
Source: this donation
Remarks: CAP/RAST/EAST-class:0
< 0.35 kU/L
Method: Immunoblot
System: EUROLineScan-Programm EUROIMMUN AG
SIgE nBos d 4 alpha-lactalbumin, Milk (f76)
Qual:
Quant: < 0.35 kU/L
Source: this donation
Remarks: CAP/RAST/EAST-class:0
< 0.35 kU/L
Method: Immunoblot
System: EUROLineScan-Programm EUROIMMUN AG
SIgE nBos d 5 beta-lactoglobulin, Milk (f77)
Qual:
Quant: < 0.35 kU/L
Source: this donation
Remarks: CAP/RAST/EAST-class:0
< 0.35 kU/L
Method: Immunoblot
System: EUROLineScan-Programm EUROIMMUN AG
SIgE nBos d 6 BSA, Cow (e204)
Qual:
Quant: < 0.35 kU/L
Source: this donation
Remarks: CAP/RAST/EAST-class:0
< 0.35 kU/L
Method: Immunoblot
System: EUROLineScan-Programm EUROIMMUN AG
SIgE nBos d 8 Casein, Milk (f78)
Qual:
Quant: < 0.35 kU/L
Source: this donation
Remarks: CAP/RAST/EAST-class:0
< 0.35 kU/L
Method: Immunoblot
System: EUROLineScan-Programm EUROIMMUN AG
Disclaimer
  • All products are for research or manufacturing purposes only and are not for direct therapeutic or diagnostic use in human or animals.
  • Biospecimens should be treated as potentially infectious. Each specimen is intended for use only in by qualified professionals who will safely handle and dispose of the products they receive.
  • Import permit for biological substances must be present for purchase.
  • This sample is not for molecular genetic studies.
CBH192773
233 mL (€8,737.50)
Will be delivered in 16 to 20 Business Days (€180.00)

Human Serum - Anti-Glutamate Decarboxylase (GAD), A... - E05.0

Donor:
Gender: Male Age: 43
Diagnosed disease:
E10.01 - Type 1 diabetes mellitus with ketoacidosis
Medication:
Kreon
Parameter:
Anti-Glutamate Decarboxylase (GAD) Anti-Thyroglobulin (aTg / TAK) Anti-Thyroid peroxidase (aTPO / MAK) TSH Receptor Antibodies (TRAb) Thyroglobulin (Tg) Thyrotropin (TSH) Thyroxine (FT4) Triglycerides Triiodothyronine (FT3)
Donor:
Gender:
Male
Age:
43 Years
BMI:
36 kg/m²
Weight:
121 kg
Height:
183 cm
Sample:
Matrix:
Serum
Condition:
perfect
Freeze-Thaw-Cycle:
0
Diseases:
  • Thyrotoxicosis with diffuse goitre [E05.0]
  • Type 1 diabetes mellitus with ketoacidosis [E10.01]
Medication:
  • Kreon
  • Lantus
  • Novorapid
  • amlodipine
  • atorvastatin
Parameter Result Ref. / Cut-Off Measuring Information
Anti-Glutamate Decarboxylase (GAD)
Qual:
Quant: < 0.60 U/mL
Source: this donation
< 0.90 U/mL
Method: RIA (Radioimmunoassay)
System: LKB 147 Gamma Counter Berthold Technologies
Anti-Thyroglobulin (aTg / TAK)
Qual:
Quant: < 50.00 IU/mL
Source: this donation
< 100 IU/mL
Method: EIA (Enzyme Immuno Assay)
System: not specified not specified
Anti-Thyroid peroxidase (aTPO / MAK)
Qual:
Quant: 39.90 kU/L
Source: this donation
< 35.00 kU/L
Method: CLIA (Chemiluminescence Immuno Assay)
System: Immulite Siemens
Anti-Thyroid peroxidase (aTPO / MAK)
Qual:
Quant: 77.00 not specified
Source: previous donation
not specified not specified
Method: not specified
System: not specified not specified
TSH Receptor Antibodies (TRAb)
Qual:
Quant: 0.80 not specified
Source: previous donation
not specified not specified
Method: not specified
System: not specified not specified
Thyroglobulin (Tg)
Qual:
Quant: 3.01 ng/mL
Source: this donation
2.00 - 70.00 ng/mL
Method: LIA (Luminescence Immuno Assay)
System: not specified not specified
Thyrotropin (TSH)
Qual:
Quant: 0.57 not specified
Source: previous donation
not specified not specified
Method: not specified
System: not specified not specified
Thyroxine (FT4)
Qual:
Quant: 13.60 not specified
Source: previous donation
not specified not specified
Method: not specified
System: not specified not specified
Triglycerides
Qual:
Quant: 1.02 mmol/L
Source: this donation
< 2.25 mmol/L
Method: not specified
System: not specified Beckman Coulter
Triiodothyronine (FT3)
Qual:
Quant: 4.00 not specified
Source: previous donation
not specified not specified
Method: not specified
System: not specified not specified
Disclaimer
  • All products are for research or manufacturing purposes only and are not for direct therapeutic or diagnostic use in human or animals.
  • Biospecimens should be treated as potentially infectious. Each specimen is intended for use only in by qualified professionals who will safely handle and dispose of the products they receive.
  • Import permit for biological substances must be present for purchase.
  • This sample is not for molecular genetic studies.
CBH180212
183 mL (€6,862.50)
Will be delivered in 16 to 20 Business Days (€180.00)

Human Li-heparin plasma - Anti-Thyroid peroxidase (aTPO / MAK),... - E03.9

Donor:
Gender: Female Age: 75 Ethnic group: European/Caucasian
Diagnosed disease:
E11.90
Medication:
Euthyrox
Parameter:
Anti-Thyroid peroxidase (aTPO / MAK) TSH Receptor Antibodies (TRAb) Thyrotropin (TSH) Thyroxine (FT4) Triiodothyronine (FT3)
Donor:
Gender:
Female
Age:
75 Years
Ethnic group:
European/Caucasian
BMI:
26 kg/m²
Weight:
74.5 kg
Height:
168 cm
Sample:
Matrix:
Li-heparin plasma
Condition:
perfect
Freeze-Thaw-Cycle:
0
Diseases:
  • Hypothyroidism, unspecified [E03.9]
  • Thyrotoxicosis with diffuse goitre [E05.0]
  • E11.90
  • hypertension
  • hypoparathyroidism - partial (not specified)
Medication:
  • Euthyrox (Dosages: 112µg)
  • Lantus (active agent: insulin glargin)
  • Metoprolol
  • Novorapid (active agent: insulin aspart)
  • simvastatine
Parameter Result Ref. / Cut-Off Measuring Information
Anti-Thyroid peroxidase (aTPO / MAK)
Qual:
Quant: 16.30 not specified
Source: previous donation
not specified not specified
Method: not specified
System: not specified not specified
TSH Receptor Antibodies (TRAb)
Qual:
Quant: 24.27 not specified
Source: previous donation
not specified not specified
Method: not specified
System: not specified not specified
Thyrotropin (TSH)
Qual:
Quant: 0.73 not specified
Source: previous donation
not specified not specified
Method: not specified
System: not specified not specified
Thyroxine (FT4)
Qual:
Quant: 18.40 not specified
Source: previous donation
not specified not specified
Method: not specified
System: not specified not specified
Triiodothyronine (FT3)
Qual:
Quant: 2.30 not specified
Source: previous donation
not specified not specified
Method: not specified
System: not specified not specified
Disclaimer
  • All products are for research or manufacturing purposes only and are not for direct therapeutic or diagnostic use in human or animals.
  • Biospecimens should be treated as potentially infectious. Each specimen is intended for use only in by qualified professionals who will safely handle and dispose of the products they receive.
  • Import permit for biological substances must be present for purchase.
  • This sample is not for molecular genetic studies.
CBH147118
1 mL (€37.50)
Will be delivered in 16 to 20 Business Days (€180.00)

Human Serum - Anti-Thyroid peroxidase (aTPO / MAK),... - E03.9

Donor:
Gender: Female Age: 75 Ethnic group: European/Caucasian
Diagnosed disease:
E11.90
Medication:
Euthyrox
Parameter:
Anti-Thyroid peroxidase (aTPO / MAK) TSH Receptor Antibodies (TRAb) Thyrotropin (TSH) Thyroxine (FT4) Triiodothyronine (FT3)
Donor:
Gender:
Female
Age:
75 Years
Ethnic group:
European/Caucasian
BMI:
26 kg/m²
Weight:
74.5 kg
Height:
168 cm
Sample:
Matrix:
Serum
Condition:
perfect
Freeze-Thaw-Cycle:
0
Diseases:
  • Hypothyroidism, unspecified [E03.9]
  • Thyrotoxicosis with diffuse goitre [E05.0]
  • E11.90
  • hypertension
  • hypoparathyroidism - partial (not specified)
Medication:
  • Euthyrox (Dosages: 112µg)
  • Lantus (active agent: insulin glargin)
  • Metoprolol
  • Novorapid (active agent: insulin aspart)
  • simvastatine
Parameter Result Ref. / Cut-Off Measuring Information
Anti-Thyroid peroxidase (aTPO / MAK)
Qual:
Quant: 16.30 not specified
Source: previous donation
not specified not specified
Method: not specified
System: not specified not specified
TSH Receptor Antibodies (TRAb)
Qual:
Quant: 24.27 not specified
Source: previous donation
not specified not specified
Method: not specified
System: not specified not specified
Thyrotropin (TSH)
Qual:
Quant: 0.73 not specified
Source: previous donation
not specified not specified
Method: not specified
System: not specified not specified
Thyroxine (FT4)
Qual:
Quant: 18.40 not specified
Source: previous donation
not specified not specified
Method: not specified
System: not specified not specified
Triiodothyronine (FT3)
Qual:
Quant: 2.30 not specified
Source: previous donation
not specified not specified
Method: not specified
System: not specified not specified
Disclaimer
  • All products are for research or manufacturing purposes only and are not for direct therapeutic or diagnostic use in human or animals.
  • Biospecimens should be treated as potentially infectious. Each specimen is intended for use only in by qualified professionals who will safely handle and dispose of the products they receive.
  • Import permit for biological substances must be present for purchase.
  • This sample is not for molecular genetic studies.
CBH147114
1 mL (€37.50)
Will be delivered in 16 to 20 Business Days (€180.00)

Human K3EDTA plasma - Anti-Thyroid peroxidase (aTPO / MAK),... - E03.9

Donor:
Gender: Female Age: 75 Ethnic group: European/Caucasian
Diagnosed disease:
E11.90
Medication:
Euthyrox
Parameter:
Anti-Thyroid peroxidase (aTPO / MAK) TSH Receptor Antibodies (TRAb) Thyrotropin (TSH) Thyroxine (FT4) Triiodothyronine (FT3)
Donor:
Gender:
Female
Age:
75 Years
Ethnic group:
European/Caucasian
BMI:
26 kg/m²
Weight:
74.5 kg
Height:
168 cm
Sample:
Matrix:
K3EDTA plasma
Condition:
perfect
Freeze-Thaw-Cycle:
0
Diseases:
  • Hypothyroidism, unspecified [E03.9]
  • Thyrotoxicosis with diffuse goitre [E05.0]
  • E11.90
  • hypertension
  • hypoparathyroidism - partial (not specified)
Medication:
  • Euthyrox (Dosages: 112µg)
  • Lantus (active agent: insulin glargin)
  • Metoprolol
  • Novorapid (active agent: insulin aspart)
  • simvastatine
Parameter Result Ref. / Cut-Off Measuring Information
Anti-Thyroid peroxidase (aTPO / MAK)
Qual:
Quant: 16.30 not specified
Source: previous donation
not specified not specified
Method: not specified
System: not specified not specified
TSH Receptor Antibodies (TRAb)
Qual:
Quant: 24.27 not specified
Source: previous donation
not specified not specified
Method: not specified
System: not specified not specified
Thyrotropin (TSH)
Qual:
Quant: 0.73 not specified
Source: previous donation
not specified not specified
Method: not specified
System: not specified not specified
Thyroxine (FT4)
Qual:
Quant: 18.40 not specified
Source: previous donation
not specified not specified
Method: not specified
System: not specified not specified
Triiodothyronine (FT3)
Qual:
Quant: 2.30 not specified
Source: previous donation
not specified not specified
Method: not specified
System: not specified not specified
Disclaimer
  • All products are for research or manufacturing purposes only and are not for direct therapeutic or diagnostic use in human or animals.
  • Biospecimens should be treated as potentially infectious. Each specimen is intended for use only in by qualified professionals who will safely handle and dispose of the products they receive.
  • Import permit for biological substances must be present for purchase.
  • This sample is not for molecular genetic studies.
CBH147115
1 mL (€37.50)
Will be delivered in 16 to 20 Business Days (€180.00)

Human Sodium heparin plasma - Anti-Thyroid peroxidase (aTPO / MAK),... - E03.9

Donor:
Gender: Female Age: 75 Ethnic group: European/Caucasian
Diagnosed disease:
E11.90
Medication:
Euthyrox
Parameter:
Anti-Thyroid peroxidase (aTPO / MAK) TSH Receptor Antibodies (TRAb) Thyrotropin (TSH) Thyroxine (FT4) Triiodothyronine (FT3)
Donor:
Gender:
Female
Age:
75 Years
Ethnic group:
European/Caucasian
BMI:
26 kg/m²
Weight:
74.5 kg
Height:
168 cm
Sample:
Matrix:
Sodium heparin plasma
Condition:
perfect
Freeze-Thaw-Cycle:
0
Diseases:
  • Hypothyroidism, unspecified [E03.9]
  • Thyrotoxicosis with diffuse goitre [E05.0]
  • E11.90
  • hypertension
  • hypoparathyroidism - partial (not specified)
Medication:
  • Euthyrox (Dosages: 112µg)
  • Lantus (active agent: insulin glargin)
  • Metoprolol
  • Novorapid (active agent: insulin aspart)
  • simvastatine
Parameter Result Ref. / Cut-Off Measuring Information
Anti-Thyroid peroxidase (aTPO / MAK)
Qual:
Quant: 16.30 not specified
Source: previous donation
not specified not specified
Method: not specified
System: not specified not specified
TSH Receptor Antibodies (TRAb)
Qual:
Quant: 24.27 not specified
Source: previous donation
not specified not specified
Method: not specified
System: not specified not specified
Thyrotropin (TSH)
Qual:
Quant: 0.73 not specified
Source: previous donation
not specified not specified
Method: not specified
System: not specified not specified
Thyroxine (FT4)
Qual:
Quant: 18.40 not specified
Source: previous donation
not specified not specified
Method: not specified
System: not specified not specified
Triiodothyronine (FT3)
Qual:
Quant: 2.30 not specified
Source: previous donation
not specified not specified
Method: not specified
System: not specified not specified
Disclaimer
  • All products are for research or manufacturing purposes only and are not for direct therapeutic or diagnostic use in human or animals.
  • Biospecimens should be treated as potentially infectious. Each specimen is intended for use only in by qualified professionals who will safely handle and dispose of the products they receive.
  • Import permit for biological substances must be present for purchase.
  • This sample is not for molecular genetic studies.
CBH147121
1 mL (€37.50)
Will be delivered in 16 to 20 Business Days (€180.00)

Human Serum - E11.90

Donor:
Gender: Female Age: 63 Ethnic group: European/Caucasian
Diagnosed disease:
E11.90 - type 2 (not specified)
Medication:
insulin
Parameter:
Anti-Hepatitis C Virus (HCV) Anti-Human Immunodeficiency Virus-1/2 (HIV-1/2) Hepatitis B Virus surface Antigen (HBsAg)
Donor:
Gender:
Female
Age:
63 Years
Ethnic group:
European/Caucasian
BMI:
56 kg/m²
Weight:
152 kg
Height:
165 cm
Sample:
Matrix:
Serum
Condition:
perfect
Freeze-Thaw-Cycle:
0
Diseases:
  • diabetes mellitus [E11.90] - type 2 (not specified)
  • hypertension
  • sleep apnoea
Medication:
  • insulin
  • metformin
Therapy:
  • cardiac valve replacement
  • thyroid surgery
Parameter Result Ref. / Cut-Off Measuring Information
Anti-Hepatitis C Virus (HCV)
Qual: negative
Quant:
Source: this donation
negative
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay)
System: Architect i 2000 sr Abbott Diagnostics
Anti-Human Immunodeficiency Virus-1/2 (HIV-1/2)
Qual: negative
Quant:
Source: this donation
negative
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay)
System: Architect i 2000 sr Abbott Diagnostics
Hepatitis B Virus surface Antigen (HBsAg)
Qual: negative
Quant:
Source: this donation
negative
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay)
System: Architect i 2000 sr Abbott Diagnostics
Disclaimer
  • All products are for research or manufacturing purposes only and are not for direct therapeutic or diagnostic use in human or animals.
  • Biospecimens should be treated as potentially infectious. Each specimen is intended for use only in by qualified professionals who will safely handle and dispose of the products they receive.
  • Import permit for biological substances must be present for purchase.
  • This sample is not for molecular genetic studies.
CBH146089
1 mL (€37.50)
Will be delivered in 16 to 20 Business Days (€180.00)

Human Serum - Glycosylated hemoglobin (HbA1, HbA1c) - E11.90

Donor:
Gender: Male Age: 68 Ethnic group: European/Caucasian
Diagnosed disease:
E11.90 - type 2 (not specified)
Medication:
DPP-4 inhibitor
Parameter:
Anti-Hepatitis C Virus (HCV) Anti-Human Immunodeficiency Virus-1/2 (HIV-1/2) Glycosylated hemoglobin (HbA1, HbA1c) Hepatitis B Virus surface Antigen (HBsAg)
Donor:
Gender:
Male
Age:
68 Years
Ethnic group:
European/Caucasian
BMI:
30 kg/m²
Weight:
98 kg
Height:
180 cm
Sample:
Matrix:
Serum
Condition:
perfect
Freeze-Thaw-Cycle:
0
Diseases:
  • diabetes mellitus [E11.90] - type 2 (not specified)
  • thyroid disease
Medication:
  • DPP-4 inhibitor
  • blood thinner (because of stroke)
  • metformin
  • no incretin mimetics
  • no insulin
Parameter Result Ref. / Cut-Off Measuring Information
Anti-Hepatitis C Virus (HCV)
Qual: negative
Quant:
Source: this donation
negative
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay)
System: Architect i 2000 sr Abbott
Anti-Human Immunodeficiency Virus-1/2 (HIV-1/2)
Qual: negative
Quant:
Source: this donation
negative
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay)
System: Architect i 2000 sr Abbott
Glycosylated hemoglobin (HbA1, HbA1c)
Qual:
Quant: 3.10 %
Source: previous donation
not specified not specified
Method: not specified
System: not specified not specified
Hepatitis B Virus surface Antigen (HBsAg)
Qual: negative
Quant:
Source: this donation
negative
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay)
System: Architect i 2000 sr Abbott
Disclaimer
  • All products are for research or manufacturing purposes only and are not for direct therapeutic or diagnostic use in human or animals.
  • Biospecimens should be treated as potentially infectious. Each specimen is intended for use only in by qualified professionals who will safely handle and dispose of the products they receive.
  • Import permit for biological substances must be present for purchase.
  • This sample is not for molecular genetic studies.
CBH170468
1 mL (€37.50)
Will be delivered in 16 to 20 Business Days (€180.00)

Human Serum - Glycosylated hemoglobin (HbA1, HbA1c) - E11.90

Donor:
Gender: Female Age: 54 Ethnic group: European/Caucasian
Diagnosed disease:
E11.90 - type 2 (reliable diagnosis)
Medication:
DuoTrav
Parameter:
Anti-Hepatitis C Virus (HCV) Anti-Human Immunodeficiency Virus-1/2 (HIV-1/2) Glycosylated hemoglobin (HbA1, HbA1c) Hepatitis B Virus surface Antigen (HBsAg)
Donor:
Gender:
Female
Age:
54 Years
Ethnic group:
European/Caucasian
BMI:
29 kg/m²
Weight:
89 kg
Height:
174 cm
Sample:
Matrix:
Serum
Condition:
perfect
Freeze-Thaw-Cycle:
0
Diseases:
  • diabetes mellitus [E11.90] - type 2 (reliable diagnosis)
  • glaucoma
  • hypothyroidism
Medication:
  • DuoTrav (Dosages: 1drop/day)
  • Janumet
  • L-thyroxine (Dosages: 125/day)
  • no incretin mimetics
  • no insulin
Parameter Result Ref. / Cut-Off Measuring Information
Anti-Hepatitis C Virus (HCV)
Qual: negative
Quant:
Source: this donation
negative
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay)
System: Architect i 2000 sr Abbott Diagnostics
Anti-Human Immunodeficiency Virus-1/2 (HIV-1/2)
Qual: negative
Quant:
Source: this donation
negative
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay)
System: Architect i 2000 sr Abbott Diagnostics
Glycosylated hemoglobin (HbA1, HbA1c)
Qual:
Quant: 6.50 %
Source: previous donation
not specified not specified
Method: not specified
System: not specified not specified
Hepatitis B Virus surface Antigen (HBsAg)
Qual: negative
Quant:
Source: this donation
negative
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay)
System: Architect i 2000 sr Abbott Diagnostics
Disclaimer
  • All products are for research or manufacturing purposes only and are not for direct therapeutic or diagnostic use in human or animals.
  • Biospecimens should be treated as potentially infectious. Each specimen is intended for use only in by qualified professionals who will safely handle and dispose of the products they receive.
  • Import permit for biological substances must be present for purchase.
  • This sample is not for molecular genetic studies.
CBH142240
1 mL (€37.50)
Will be delivered in 16 to 20 Business Days (€180.00)

Human Serum - Anti-Thyroglobulin (aTg / TAK), Anti-... - E06.3

Donor:
Gender: Male Age: 18 Ethnic group: European/Caucasian
Diagnosed disease:
E10.90
Medication:
Levemir
Parameter:
Anti-Thyroglobulin (aTg / TAK) Anti-Thyroid peroxidase (aTPO / MAK) Thyrotropin (TSH) Thyroxine (FT4) Triiodothyronine (FT3)
Donor:
Gender:
Male
Age:
18 Years
Ethnic group:
European/Caucasian
BMI:
28 kg/m²
Weight:
83.5 kg
Height:
173 cm
Sample:
Matrix:
Serum
Condition:
perfect
Freeze-Thaw-Cycle:
0
Diseases:
  • Autoimmune thyroiditis [E06.3]
  • E10.90
  • vitamin D deficiency
Medication:
  • Levemir
  • Vigantoletten (specific information from donor: Vigantolette 500 IU)
Parameter Result Ref. / Cut-Off Measuring Information
Anti-Thyroglobulin (aTg / TAK)
Qual:
Quant: 230.90 IU/mL
Source: previous donation
not specified not specified
Method: not specified
System: not specified not specified
Anti-Thyroid peroxidase (aTPO / MAK)
Qual:
Quant: 149.60 IU/mL
Source: previous donation
not specified not specified
Method: not specified
System: not specified not specified
Thyrotropin (TSH)
Qual:
Quant: 2.98 mIU/L
Source: previous donation
not specified not specified
Method: not specified
System: not specified not specified
Thyroxine (FT4)
Qual:
Quant: 9.80 pmol/L
Source: previous donation
not specified not specified
Method: not specified
System: not specified not specified
Triiodothyronine (FT3)
Qual:
Quant: 6.85 pmol/L
Source: previous donation
not specified not specified
Method: not specified
System: not specified not specified
Disclaimer
  • All products are for research or manufacturing purposes only and are not for direct therapeutic or diagnostic use in human or animals.
  • Biospecimens should be treated as potentially infectious. Each specimen is intended for use only in by qualified professionals who will safely handle and dispose of the products they receive.
  • Import permit for biological substances must be present for purchase.
  • This sample is not for molecular genetic studies.
CBH167019
1 mL (€37.50)
Will be delivered in 16 to 20 Business Days (€180.00)

Human Serum - Glycosylated hemoglobin (HbA1, HbA1c) - E11.2

Donor:
Gender: Female Age: 67 Ethnic group: European/Caucasian
Diagnosed disease:
E11.2 - Type 2 diabetes mellitus with renal complications - type 2 (not specified)
Medication:
L-thyroxine
Parameter:
Anti-Hepatitis C Virus (HCV) Anti-Human Immunodeficiency Virus-1/2 (HIV-1/2) Glycosylated hemoglobin (HbA1, HbA1c) Hepatitis B Virus surface Antigen (HBsAg)
Donor:
Gender:
Female
Age:
67 Years
Ethnic group:
European/Caucasian
BMI:
29 kg/m²
Weight:
89 kg
Height:
174 cm
Sample:
Matrix:
Serum
Condition:
perfect
Freeze-Thaw-Cycle:
0
Diseases:
  • Hashimotos thyroiditis
  • diabetes mellitus [E11.2] - type 2 (not specified)
  • hypertension
  • hyperuricaemia
Medication:
  • L-thyroxine (Dosages: 37.5not specified)
  • Ramipril (Dosages: 5mg/day)
  • allopurinol (Dosages: 100mg/day)
  • metformin (Dosages: 1500/day)
  • no incretin mimetics
  • no insulin
Parameter Result Ref. / Cut-Off Measuring Information
Anti-Hepatitis C Virus (HCV)
Qual: negative
Quant:
Source: this donation
negative
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay)
System: Architect i 2000 sr Abbott Diagnostics
Anti-Human Immunodeficiency Virus-1/2 (HIV-1/2)
Qual: negative
Quant:
Source: this donation
negative
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay)
System: Architect i 2000 sr Abbott Diagnostics
Glycosylated hemoglobin (HbA1, HbA1c)
Qual:
Quant: 7.10 not specified
Source: previous donation
not specified not specified
Method: not specified
System: not specified not specified
Hepatitis B Virus surface Antigen (HBsAg)
Qual: negative
Quant:
Source: this donation
negative
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay)
System: Architect i 2000 sr Abbott Diagnostics
Disclaimer
  • All products are for research or manufacturing purposes only and are not for direct therapeutic or diagnostic use in human or animals.
  • Biospecimens should be treated as potentially infectious. Each specimen is intended for use only in by qualified professionals who will safely handle and dispose of the products they receive.
  • Import permit for biological substances must be present for purchase.
  • This sample is not for molecular genetic studies.
CBH143042
1 mL (€37.50)
Will be delivered in 16 to 20 Business Days (€180.00)

Human Serum - M15.1

Donor:
Gender: Female Age: 72 Ethnic group: European/Caucasian
Diagnosed disease:
E10.40 - type 1 (not specified)
Medication:
Exforge
Parameter:
Anti-Hepatitis C Virus (HCV) Anti-Human Immunodeficiency Virus-1/2 (HIV-1/2) Hepatitis B Virus surface Antigen (HBsAg)
Donor:
Gender:
Female
Age:
72 Years
Ethnic group:
European/Caucasian
BMI:
24 kg/m²
Weight:
63 kg
Height:
163 cm
Sample:
Matrix:
Serum
Condition:
perfect
Freeze-Thaw-Cycle:
0
Diseases:
  • Heberden nodes (with arthropathy) [M15.1]
  • diabetes mellitus [E10.40] - type 1 (not specified)
Medication:
  • Exforge
  • Humalog
  • Torasemid
  • Toujeo
  • amlodipine
Parameter Result Ref. / Cut-Off Measuring Information
Anti-Hepatitis C Virus (HCV)
Qual: negative
Quant:
Source: this donation
negative
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay)
System: Architect i 2000 sr Abbott Diagnostics
Anti-Human Immunodeficiency Virus-1/2 (HIV-1/2)
Qual: negative
Quant:
Source: this donation
negative
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay)
System: Architect i 2000 sr Abbott Diagnostics
Hepatitis B Virus surface Antigen (HBsAg)
Qual: negative
Quant:
Source: this donation
negative
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay)
System: Architect i 2000 sr Abbott Diagnostics
Disclaimer
  • All products are for research or manufacturing purposes only and are not for direct therapeutic or diagnostic use in human or animals.
  • Biospecimens should be treated as potentially infectious. Each specimen is intended for use only in by qualified professionals who will safely handle and dispose of the products they receive.
  • Import permit for biological substances must be present for purchase.
  • This sample is not for molecular genetic studies.
CBH198214
1 mL (€37.50)
Will be delivered in 16 to 20 Business Days (€180.00)

Human Serum - Blood sugar (fasting), Glycosylated h... - E11.9

Donor:
Gender: Female Age: 75 Ethnic group: European/Caucasian
Diagnosed disease:
E11.9 - Type 2 diabetes mellitus without complications - type 2 (not specified)
Medication:
L-thyroxine
Parameter:
Blood sugar (fasting) Glycosylated hemoglobin (HbA1, HbA1c)
Donor:
Gender:
Female
Age:
75 Years
Ethnic group:
European/Caucasian
BMI:
41 kg/m²
Weight:
112 kg
Height:
165 cm
Sample:
Matrix:
Serum
Condition:
perfect
Freeze-Thaw-Cycle:
0
Diseases:
  • diabetes mellitus [E11.9] - type 2 (not specified)
  • thyroid disease
Medication:
  • L-thyroxine
  • Toujeo (specific information from donor: Toujeo 300 U/ml)
  • atorvastatin
  • insulin
  • no incretin mimetics
Parameter Result Ref. / Cut-Off Measuring Information
Blood sugar (fasting)
Qual:
Quant: 135.00 mg/dl
Source: this donation
not specified not specified
Method: not specified
System: not specified not specified
Glycosylated hemoglobin (HbA1, HbA1c)
Qual:
Quant: 7.60 %
Source: previous donation
not specified not specified
Method: not specified
System: not specified not specified
Disclaimer
  • All products are for research or manufacturing purposes only and are not for direct therapeutic or diagnostic use in human or animals.
  • Biospecimens should be treated as potentially infectious. Each specimen is intended for use only in by qualified professionals who will safely handle and dispose of the products they receive.
  • Import permit for biological substances must be present for purchase.
  • This sample is not for molecular genetic studies.
CBH165497
1 mL (€37.50)
Will be delivered in 16 to 20 Business Days (€180.00)

Human Serum - E11.90

Donor:
Gender: Female Age: 83 Ethnic group: European/Caucasian
Diagnosed disease:
E11.90 - type 2 (not specified)
Medication:
ASS
Parameter:
Anti-Hepatitis C Virus (HCV) Anti-Human Immunodeficiency Virus-1/2 (HIV-1/2) Hepatitis B Virus surface Antigen (HBsAg)
Donor:
Gender:
Female
Age:
83 Years
Ethnic group:
European/Caucasian
BMI:
30 kg/m²
Weight:
75 kg
Height:
158 cm
Sample:
Matrix:
Serum
Condition:
perfect
Freeze-Thaw-Cycle:
0
Diseases:
  • diabetes mellitus [E11.90] - type 2 (not specified)
Medication:
  • ASS
  • Metoprolol
  • Ramipril
  • amlodipine
  • no incretin mimetics
  • no insulin
  • none
Parameter Result Ref. / Cut-Off Measuring Information
Anti-Hepatitis C Virus (HCV)
Qual: negative
Quant:
Source: this donation
negative
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay)
System: Architect i 2000 sr Abbott
Anti-Human Immunodeficiency Virus-1/2 (HIV-1/2)
Qual: negative
Quant:
Source: this donation
negative
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay)
System: Architect i 2000 sr Abbott
Hepatitis B Virus surface Antigen (HBsAg)
Qual: negative
Quant:
Source: this donation
negative
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay)
System: Architect i 2000 sr Abbott
Disclaimer
  • All products are for research or manufacturing purposes only and are not for direct therapeutic or diagnostic use in human or animals.
  • Biospecimens should be treated as potentially infectious. Each specimen is intended for use only in by qualified professionals who will safely handle and dispose of the products they receive.
  • Import permit for biological substances must be present for purchase.
  • This sample is not for molecular genetic studies.
CBH169795
1 mL (€37.50)
Will be delivered in 16 to 20 Business Days (€180.00)

Human Serum - E11.90

Donor:
Gender: Female Age: 79 Ethnic group: European/Caucasian
Diagnosed disease:
E11.90
Medication:
Bisoprolol
Parameter:
Anti-Hepatitis C Virus (HCV) Anti-Human Immunodeficiency Virus-1/2 (HIV-1/2) Hepatitis B Virus surface Antigen (HBsAg)
Donor:
Gender:
Female
Age:
79 Years
Ethnic group:
European/Caucasian
BMI:
32 kg/m²
Weight:
75 kg
Height:
153 cm
Sample:
Matrix:
Serum
Condition:
perfect
Freeze-Thaw-Cycle:
0
Diseases:
  • diabetes mellitus [E11.90]
  • gastritis
  • hyperlipoproteinaemia
  • hypertension
Medication:
  • Bisoprolol
  • Ramipril
  • Xarelto
  • no incretin mimetics
  • no insulin
Parameter Result Ref. / Cut-Off Measuring Information
Anti-Hepatitis C Virus (HCV)
Qual: negative
Quant:
Source: this donation
negative
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay)
System: Architect i 2000 sr Abbott Diagnostics
Anti-Human Immunodeficiency Virus-1/2 (HIV-1/2)
Qual: negative
Quant:
Source: this donation
negative
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay)
System: Architect i 2000 sr Abbott Diagnostics
Hepatitis B Virus surface Antigen (HBsAg)
Qual: negative
Quant:
Source: this donation
negative
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay)
System: Architect i 2000 sr Abbott Diagnostics
Disclaimer
  • All products are for research or manufacturing purposes only and are not for direct therapeutic or diagnostic use in human or animals.
  • Biospecimens should be treated as potentially infectious. Each specimen is intended for use only in by qualified professionals who will safely handle and dispose of the products they receive.
  • Import permit for biological substances must be present for purchase.
  • This sample is not for molecular genetic studies.
CBH165539
1 mL (€37.50)
Will be delivered in 16 to 20 Business Days (€180.00)

Human Serum - Glycosylated hemoglobin (HbA1, HbA1c) - E11.9

Donor:
Gender: Female Age: 50 Ethnic group: European/Caucasian
Diagnosed disease:
E11.9 - Type 2 diabetes mellitus without complications - type 2 (not specified)
Medication:
Metex
Parameter:
Anti-Hepatitis C Virus (HCV) Anti-Human Immunodeficiency Virus-1/2 (HIV-1/2) Glycosylated hemoglobin (HbA1, HbA1c) Hepatitis B Virus surface Antigen (HBsAg)
Donor:
Gender:
Female
Age:
50 Years
Ethnic group:
European/Caucasian
BMI:
31 kg/m²
Weight:
90 kg
Height:
170 cm
Sample:
Matrix:
Serum
Condition:
perfect
Freeze-Thaw-Cycle:
0
Diseases:
  • diabetes mellitus [E11.9] - type 2 (not specified)
  • rheumatism - 01 (not specified)
  • thyroid disease - 01 (not specified)
Medication:
  • Metex
  • Novorapid
  • Protaphan
  • insulin
  • metformin
Parameter Result Ref. / Cut-Off Measuring Information
Anti-Hepatitis C Virus (HCV)
Qual: negative
Quant:
Source: this donation
negative
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay)
System: Architect i 2000 sr Abbott
Anti-Human Immunodeficiency Virus-1/2 (HIV-1/2)
Qual: negative
Quant:
Source: this donation
negative
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay)
System: Architect i 2000 sr Abbott
Glycosylated hemoglobin (HbA1, HbA1c)
Qual:
Quant: 6.30 %
Source: previous donation
not specified not specified
Method: not specified
System: not specified not specified
Hepatitis B Virus surface Antigen (HBsAg)
Qual: negative
Quant:
Source: this donation
negative
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay)
System: Architect i 2000 sr Abbott
Disclaimer
  • All products are for research or manufacturing purposes only and are not for direct therapeutic or diagnostic use in human or animals.
  • Biospecimens should be treated as potentially infectious. Each specimen is intended for use only in by qualified professionals who will safely handle and dispose of the products they receive.
  • Import permit for biological substances must be present for purchase.
  • This sample is not for molecular genetic studies.
CBH165636
1 mL (€37.50)
Will be delivered in 16 to 20 Business Days (€180.00)

Human Serum - Blood glucose (postprandial), Glycosy... - E11.9

Donor:
Gender: Female Age: 65 Ethnic group: European/Caucasian
Diagnosed disease:
E11.9 - Type 2 diabetes mellitus without complications - type 2 (not specified)
Medication:
metformin
Parameter:
Anti-Hepatitis C Virus (HCV) Anti-Human Immunodeficiency Virus-1/2 (HIV-1/2) Blood glucose (postprandial) Glycosylated hemoglobin (HbA1, HbA1c) Hepatitis B Virus surface Antigen (HBsAg)
Donor:
Gender:
Female
Age:
65 Years
Ethnic group:
European/Caucasian
BMI:
33 kg/m²
Weight:
85 kg
Height:
161 cm
Sample:
Matrix:
Serum
Condition:
perfect
Freeze-Thaw-Cycle:
0
Diseases:
  • asthma
  • diabetes mellitus [E11.9] - type 2 (not specified)
Medication:
  • metformin
  • no insulin
Parameter Result Ref. / Cut-Off Measuring Information
Anti-Hepatitis C Virus (HCV)
Qual: negative
Quant:
Source: this donation
negative
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay)
System: Architect i 2000 sr Abbott Diagnostics
Anti-Human Immunodeficiency Virus-1/2 (HIV-1/2)
Qual: negative
Quant:
Source: this donation
negative
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay)
System: Architect i 2000 sr Abbott Diagnostics
Blood glucose (postprandial)
Qual:
Quant: 132.00 mg/dl
Source: this donation
not specified not specified
Method: not specified
System: not specified not specified
Glycosylated hemoglobin (HbA1, HbA1c)
Qual:
Quant: 5.70 %
Source: previous donation
not specified not specified
Method: not specified
System: not specified not specified
Hepatitis B Virus surface Antigen (HBsAg)
Qual: negative
Quant:
Source: this donation
negative
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay)
System: Architect i 2000 sr Abbott Diagnostics
Disclaimer
  • All products are for research or manufacturing purposes only and are not for direct therapeutic or diagnostic use in human or animals.
  • Biospecimens should be treated as potentially infectious. Each specimen is intended for use only in by qualified professionals who will safely handle and dispose of the products they receive.
  • Import permit for biological substances must be present for purchase.
  • This sample is not for molecular genetic studies.
CBH165494
1 mL (€37.50)
Will be delivered in 16 to 20 Business Days (€180.00)

Human Serum - E11.90

Donor:
Gender: Female Age: 72 Ethnic group: European/Caucasian
Diagnosed disease:
E11.90
Medication:
Nebivolol
Parameter:
Anti-Hepatitis C Virus (HCV) Anti-Human Immunodeficiency Virus-1/2 (HIV-1/2) Hepatitis B Virus surface Antigen (HBsAg)
Donor:
Gender:
Female
Age:
72 Years
Ethnic group:
European/Caucasian
BMI:
32 kg/m²
Weight:
80 kg
Height:
158 cm
Sample:
Matrix:
Serum
Condition:
perfect
Freeze-Thaw-Cycle:
0
Diseases:
  • diabetes mellitus [E11.90]
  • hyperlipoproteinaemia
  • hypertension
Medication:
  • Nebivolol
  • amlodipine
  • metfomin
  • no incretin mimetics
  • no insulin
  • simvastatine
Parameter Result Ref. / Cut-Off Measuring Information
Anti-Hepatitis C Virus (HCV)
Qual: negative
Quant:
Source: this donation
negative
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay)
System: Architect i 2000 sr Abbott Diagnostics
Anti-Human Immunodeficiency Virus-1/2 (HIV-1/2)
Qual: negative
Quant:
Source: this donation
negative
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay)
System: Architect i 2000 sr Abbott Diagnostics
Hepatitis B Virus surface Antigen (HBsAg)
Qual: negative
Quant:
Source: this donation
negative
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay)
System: Architect i 2000 sr Abbott Diagnostics
Disclaimer
  • All products are for research or manufacturing purposes only and are not for direct therapeutic or diagnostic use in human or animals.
  • Biospecimens should be treated as potentially infectious. Each specimen is intended for use only in by qualified professionals who will safely handle and dispose of the products they receive.
  • Import permit for biological substances must be present for purchase.
  • This sample is not for molecular genetic studies.
CBH165537
1 mL (€37.50)
Will be delivered in 16 to 20 Business Days (€180.00)

Human Serum - Blood glucose (postprandial), Glycosy... - E78.2

Donor:
Gender: Female Age: 41 Ethnic group: Not specified
Diagnosed disease:
E11.9 - Type 2 diabetes mellitus without complications - type 2 (not specified)
Medication:
Prednisolon
Parameter:
Anti-Hepatitis C Virus (HCV) Anti-Human Immunodeficiency Virus-1/2 (HIV-1/2) Blood glucose (postprandial) Glycosylated hemoglobin (HbA1, HbA1c) Hepatitis B Virus surface Antigen (HBsAg)
Donor:
Gender:
Female
Age:
41 Years
Ethnic group:
Not specified
BMI:
32 kg/m²
Weight:
84 kg
Height:
162 cm
Sample:
Matrix:
Serum
Condition:
perfect
Freeze-Thaw-Cycle:
0
Diseases:
  • Mixed hyperlipidaemia [E78.2]
  • diabetes mellitus [E11.9] - type 2 (not specified)
Medication:
  • Prednisolon (specific information from donor: Prednisolon 5 mg)
  • insulin
  • metformin
  • no incretin mimetics
Parameter Result Ref. / Cut-Off Measuring Information
Anti-Hepatitis C Virus (HCV)
Qual: negative
Quant:
Source: this donation
negative
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay)
System: Architect i 2000 sr Abbott
Anti-Human Immunodeficiency Virus-1/2 (HIV-1/2)
Qual: negative
Quant:
Source: this donation
negative
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay)
System: Architect i 2000 sr Abbott
Blood glucose (postprandial)
Qual:
Quant: 173 mg/dl
Source: this donation
Method: not specified
Glycosylated hemoglobin (HbA1, HbA1c)
Qual:
Quant: 7.10 %
Source: previous donation
not specified not specified
Method: not specified
System: not specified not specified
Glycosylated hemoglobin (HbA1, HbA1c)
Qual:
Quant: 7.30 %
Source: previous donation
not specified not specified
Method: not specified
System: not specified not specified
Hepatitis B Virus surface Antigen (HBsAg)
Qual: negative
Quant:
Source: this donation
negative
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay)
System: Architect i 2000 sr Abbott
Disclaimer
  • All products are for research or manufacturing purposes only and are not for direct therapeutic or diagnostic use in human or animals.
  • Biospecimens should be treated as potentially infectious. Each specimen is intended for use only in by qualified professionals who will safely handle and dispose of the products they receive.
  • Import permit for biological substances must be present for purchase.
  • This sample is not for molecular genetic studies.
CBH165459
1 mL (€37.50)
Will be delivered in 16 to 20 Business Days (€180.00)

Human Serum - Glycosylated hemoglobin (HbA1, HbA1c) - E11.90

Donor:
Gender: Male Age: 64 Ethnic group: European/Caucasian
Diagnosed disease:
E11.90 - type 2 (not specified)
Medication:
DPP-4 inhibitor
Parameter:
Anti-Hepatitis C Virus (HCV) Anti-Human Immunodeficiency Virus-1/2 (HIV-1/2) Glycosylated hemoglobin (HbA1, HbA1c) Hepatitis B Virus surface Antigen (HBsAg)
Donor:
Gender:
Male
Age:
64 Years
Ethnic group:
European/Caucasian
BMI:
36 kg/m²
Weight:
128 kg
Height:
188 cm
Sample:
Matrix:
Serum
Condition:
perfect
Freeze-Thaw-Cycle:
0
Diseases:
  • coronary heart disease
  • diabetes mellitus [E11.90] - type 2 (not specified)
  • hypertension
Medication:
  • DPP-4 inhibitor
  • metformin
  • no incretin mimetics
  • no insulin
Parameter Result Ref. / Cut-Off Measuring Information
Anti-Hepatitis C Virus (HCV)
Qual: negative
Quant:
Source: this donation
negative
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay)
System: Architect i 2000 sr Abbott
Anti-Human Immunodeficiency Virus-1/2 (HIV-1/2)
Qual: negative
Quant:
Source: this donation
negative
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay)
System: Architect i 2000 sr Abbott
Glycosylated hemoglobin (HbA1, HbA1c)
Qual:
Quant: 6.20 %
Source: previous donation
not specified not specified
Method: not specified
System: not specified not specified
Hepatitis B Virus surface Antigen (HBsAg)
Qual: negative
Quant:
Source: this donation
negative
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay)
System: Architect i 2000 sr Abbott Diagnostics
Hepatitis B Virus surface Antigen (HBsAg)
Qual: negative
Quant:
Source: this donation
negative
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay)
System: Architect i 2000 sr Abbott
Disclaimer
  • All products are for research or manufacturing purposes only and are not for direct therapeutic or diagnostic use in human or animals.
  • Biospecimens should be treated as potentially infectious. Each specimen is intended for use only in by qualified professionals who will safely handle and dispose of the products they receive.
  • Import permit for biological substances must be present for purchase.
  • This sample is not for molecular genetic studies.
CBH165470
1 mL (€37.50)
Will be delivered in 16 to 20 Business Days (€180.00)

Human Serum - Glycosylated hemoglobin (HbA1, HbA1c) - E11.90

Donor:
Gender: Female Age: 72 Ethnic group: European/Caucasian
Diagnosed disease:
E11.90
Medication:
Candesartan
Parameter:
Anti-Hepatitis C Virus (HCV) Anti-Human Immunodeficiency Virus-1/2 (HIV-1/2) Glycosylated hemoglobin (HbA1, HbA1c) Hepatitis B Virus surface Antigen (HBsAg)
Donor:
Gender:
Female
Age:
72 Years
Ethnic group:
European/Caucasian
BMI:
30 kg/m²
Weight:
84 kg
Height:
168 cm
Sample:
Matrix:
Serum
Condition:
perfect
Freeze-Thaw-Cycle:
0
Diseases:
  • diabetes mellitus [E11.90]
  • hypertension
  • polyarthritis
Medication:
  • Candesartan
  • amlodipine
  • metfomin
  • no incretin mimetics
  • no insulin
Parameter Result Ref. / Cut-Off Measuring Information
Anti-Hepatitis C Virus (HCV)
Qual: negative
Quant:
Source: this donation
negative
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay)
System: Architect i 2000 sr Abbott Diagnostics
Anti-Human Immunodeficiency Virus-1/2 (HIV-1/2)
Qual: negative
Quant:
Source: this donation
negative
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay)
System: Architect i 2000 sr Abbott Diagnostics
Glycosylated hemoglobin (HbA1, HbA1c)
Qual:
Quant: 6.7 %
Source: previous donation
not specified not specified
Method: not specified
System: not specified not specified
Hepatitis B Virus surface Antigen (HBsAg)
Qual: negative
Quant:
Source: this donation
negative
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay)
System: Architect i 2000 sr Abbott Diagnostics
Disclaimer
  • All products are for research or manufacturing purposes only and are not for direct therapeutic or diagnostic use in human or animals.
  • Biospecimens should be treated as potentially infectious. Each specimen is intended for use only in by qualified professionals who will safely handle and dispose of the products they receive.
  • Import permit for biological substances must be present for purchase.
  • This sample is not for molecular genetic studies.
CBH165508
1 mL (€37.50)
Will be delivered in 16 to 20 Business Days (€180.00)

Human Serum - Blood sugar (fasting), Glycosylated h... - E11.9

Donor:
Gender: Female Age: 74 Ethnic group: European/Caucasian
Diagnosed disease:
E11.9 - Type 2 diabetes mellitus without complications - type 2 (not specified)
Medication:
incretin mimetics
Parameter:
Anti-Hepatitis C Virus (HCV) Anti-Human Immunodeficiency Virus-1/2 (HIV-1/2) Blood sugar (fasting) Glycosylated hemoglobin (HbA1, HbA1c) Hepatitis B Virus surface Antigen (HBsAg)
Donor:
Gender:
Female
Age:
74 Years
Ethnic group:
European/Caucasian
BMI:
29 kg/m²
Weight:
68.8 kg
Height:
155 cm
Sample:
Matrix:
Serum
Condition:
perfect
Freeze-Thaw-Cycle:
0
Diseases:
  • diabetes mellitus [E11.9] - type 2 (not specified)
  • hypothyroidism
Medication:
  • incretin mimetics
  • metformin
  • no insulin
Parameter Result Ref. / Cut-Off Measuring Information
Anti-Hepatitis C Virus (HCV)
Qual: negative
Quant:
Source: this donation
negative
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay)
System: Architect i 2000 sr Abbott Diagnostics
Anti-Human Immunodeficiency Virus-1/2 (HIV-1/2)
Qual: negative
Quant:
Source: this donation
negative
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay)
System: Architect i 2000 sr Abbott Diagnostics
Blood sugar (fasting)
Qual:
Quant: 78.00 mg/dl
Source: this donation
not specified not specified
Method: not specified
System: not specified not specified
Glycosylated hemoglobin (HbA1, HbA1c)
Qual:
Quant: 6.30 %
Source: previous donation
not specified not specified
Method: not specified
System: not specified not specified
Hepatitis B Virus surface Antigen (HBsAg)
Qual: negative
Quant:
Source: this donation
negative
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay)
System: Architect i 2000 sr Abbott Diagnostics
Disclaimer
  • All products are for research or manufacturing purposes only and are not for direct therapeutic or diagnostic use in human or animals.
  • Biospecimens should be treated as potentially infectious. Each specimen is intended for use only in by qualified professionals who will safely handle and dispose of the products they receive.
  • Import permit for biological substances must be present for purchase.
  • This sample is not for molecular genetic studies.
CBH165492
1 mL (€37.50)
Will be delivered in 16 to 20 Business Days (€180.00)

Human Serum - E11.90

Donor:
Gender: Male Age: 75 Ethnic group: European/Caucasian
Diagnosed disease:
E11.90
Medication:
Candesartan
Parameter:
Anti-Hepatitis C Virus (HCV) Anti-Human Immunodeficiency Virus-1/2 (HIV-1/2) Hepatitis B Virus surface Antigen (HBsAg)
Donor:
Gender:
Male
Age:
75 Years
Ethnic group:
European/Caucasian
BMI:
29 kg/m²
Weight:
90 kg
Height:
177 cm
Sample:
Matrix:
Serum
Condition:
perfect
Freeze-Thaw-Cycle:
0
Diseases:
  • diabetes mellitus [E11.90]
  • hyperlipoproteinaemia
  • hypertension
Medication:
  • Candesartan
  • amlodipine
  • metfomin
  • no incretin mimetics
  • no insulin
Parameter Result Ref. / Cut-Off Measuring Information
Anti-Hepatitis C Virus (HCV)
Qual: negative
Quant:
Source: this donation
negative
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay)
System: Architect i 2000 sr Abbott Diagnostics
Anti-Human Immunodeficiency Virus-1/2 (HIV-1/2)
Qual: negative
Quant:
Source: this donation
negative
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay)
System: Architect i 2000 sr Abbott Diagnostics
Hepatitis B Virus surface Antigen (HBsAg)
Qual: negative
Quant:
Source: this donation
negative
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay)
System: Architect i 2000 sr Abbott Diagnostics
Disclaimer
  • All products are for research or manufacturing purposes only and are not for direct therapeutic or diagnostic use in human or animals.
  • Biospecimens should be treated as potentially infectious. Each specimen is intended for use only in by qualified professionals who will safely handle and dispose of the products they receive.
  • Import permit for biological substances must be present for purchase.
  • This sample is not for molecular genetic studies.
CBH198235
1 mL (€37.50)
Will be delivered in 16 to 20 Business Days (€180.00)

Human Serum - E11.90

Donor:
Gender: Female Age: 75 Ethnic group: European/Caucasian
Diagnosed disease:
E11.90
Medication:
L-thyroxine
Parameter:
Hepatitis B Virus surface Antigen (HBsAg) Hepatitis C Virus ribonucleic acid (HCV-RNA) Human Immunodeficiency Virus type 1 ribonucleic acid (HIV-1-RNA)
Donor:
Gender:
Female
Age:
75 Years
Ethnic group:
European/Caucasian
BMI:
18 kg/m²
Weight:
52 kg
Height:
160 cm
Sample:
Matrix:
Serum
Condition:
perfect
Freeze-Thaw-Cycle:
0
Diseases:
  • E11.90
  • atrial fibrillation
Medication:
  • L-thyroxine (specific information from donor: L-thyroxine 100)
  • metformin
  • no insulin
Therapy:
  • surgery
Parameter Result Ref. / Cut-Off Measuring Information
Hepatitis B Virus surface Antigen (HBsAg)
Qual: negative
Quant:
Source: this donation
negative
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay)
System: Architect i 2000 sr Abbott Diagnostics
Hepatitis C Virus ribonucleic acid (HCV-RNA)
Qual: negative
Quant:
Source: this donation
negative
Method: qPCR (Real-Time Quantitative PCR)
System: Cobas Ampliprep/Cobas TaqMan Roche
Human Immunodeficiency Virus type 1 ribonucleic acid (HIV-1-RNA)
Qual: negative
Quant:
Source: this donation
negative
Method: PCR (Polymerase Chain Reaction)
System: Cobas Ampliprep/Cobas TaqMan Roche
Disclaimer
  • All products are for research or manufacturing purposes only and are not for direct therapeutic or diagnostic use in human or animals.
  • Biospecimens should be treated as potentially infectious. Each specimen is intended for use only in by qualified professionals who will safely handle and dispose of the products they receive.
  • Import permit for biological substances must be present for purchase.
  • This sample is not for molecular genetic studies.
CBH165346
1 mL (€75.00)
Will be delivered in 16 to 20 Business Days (€180.00)

Human Serum - Anti-Glutamate Decarboxylase (GAD), A... - E03.9

Donor:
Gender: Male Age: 35 Ethnic group: European/Caucasian
Diagnosed disease:
E10.9 - Type 1 diabetes mellitus without complications
Medication:
Lantus
Parameter:
Anti-Glutamate Decarboxylase (GAD) Anti-Insulin (IAA) Anti-Protein Tyrosine Phosphatase-like Protein IA-2 Antibodies (IA-2) TSH Receptor Antibodies (TRAb) Thyrotropin (TSH) Thyroxine (FT4) Triiodothyronine (FT3)
Donor:
Gender:
Male
Age:
35 Years
Ethnic group:
European/Caucasian
BMI:
24 kg/m²
Weight:
74 kg
Height:
177 cm
Sample:
Matrix:
Serum
Condition:
slightly turbid
Freeze-Thaw-Cycle:
0
Diseases:
  • Hypothyroidism, unspecified [E03.9]
  • Type 1 diabetes mellitus without complications [E10.9]
  • hyperprolactinaemia
Medication:
  • Lantus (active agent: insulin glargin)
  • Novorapid (active agent: insulin aspart)
Parameter Result Ref. / Cut-Off Measuring Information
Anti-Glutamate Decarboxylase (GAD)
Qual:
Quant: 106.10 U/mL
Source: this donation
< 1.00 U/mL
Remarks: reference range changed, before: < 0,90
Method: RIA (Radioimmunoassay)
System: LKB 147 Gamma Counter Berthold Technologies
Anti-Insulin (IAA)
Qual:
Quant: 0.06 U/mL
Source: this donation
< 0.40 U/mL
Method: RIA (Radioimmunoassay)
System: not specified not specified
Anti-Protein Tyrosine Phosphatase-like Protein IA-2 Antibodies (IA-2)
Qual:
Quant: 80.90 U/mL
Source: this donation
< 10.00 U/mL
Method: ELISA (Enzyme Linked Immunosorbent Assay)
System: Tecan Sunrise Photometer Tecan Trading AG
TSH Receptor Antibodies (TRAb)
Qual:
Quant: < 0.30 not specified
Source: previous donation
not specified not specified
Method: not specified
System: not specified not specified
Thyrotropin (TSH)
Qual:
Quant: 2.26 mU/L
Source: this donation
Remarks: basal
0.35 - 4.94 mU/L
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay)
System: Architect i 2000 sr Abbott Diagnostics
Thyrotropin (TSH)
Qual:
Quant: 5.33 not specified
Source: previous donation
not specified not specified
Method: not specified
System: not specified not specified
Thyroxine (FT4)
Qual:
Quant: 12.90 not specified
Source: previous donation
not specified not specified
Method: not specified
System: not specified not specified
Triiodothyronine (FT3)
Qual:
Quant: 3.70 not specified
Source: previous donation
not specified not specified
Method: not specified
System: not specified not specified
Disclaimer
  • All products are for research or manufacturing purposes only and are not for direct therapeutic or diagnostic use in human or animals.
  • Biospecimens should be treated as potentially infectious. Each specimen is intended for use only in by qualified professionals who will safely handle and dispose of the products they receive.
  • Import permit for biological substances must be present for purchase.
  • This sample is not for molecular genetic studies.
CBH192176
201 mL (€7,537.50)
Will be delivered in 16 to 20 Business Days (€180.00)

Human Serum - Blood glucose (postprandial), Glycosy... - E11.9

Donor:
Gender: Female Age: 73 Ethnic group: European/Caucasian
Diagnosed disease:
E11.9 - Type 2 diabetes mellitus without complications - type 2 (not specified)
Medication:
Lantus
Parameter:
Anti-Hepatitis C Virus (HCV) Anti-Human Immunodeficiency Virus-1/2 (HIV-1/2) Blood glucose (postprandial) Glycosylated hemoglobin (HbA1, HbA1c) Hepatitis B Virus surface Antigen (HBsAg)
Donor:
Gender:
Female
Age:
73 Years
Ethnic group:
European/Caucasian
BMI:
38 kg/m²
Weight:
71.5 kg
Height:
138 cm
Sample:
Matrix:
Serum
Condition:
perfect
Freeze-Thaw-Cycle:
0
Diseases:
  • diabetes mellitus [E11.9] - type 2 (not specified)
Medication:
  • Lantus
  • Liprolog
  • insulin
  • no incretin mimetics
Parameter Result Ref. / Cut-Off Measuring Information
Anti-Hepatitis C Virus (HCV)
Qual: negative
Quant:
Source: this donation
negative
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay)
System: Architect i 2000 sr Abbott
Anti-Human Immunodeficiency Virus-1/2 (HIV-1/2)
Qual: negative
Quant:
Source: this donation
negative
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay)
System: Architect i 2000 sr Abbott
Blood glucose (postprandial)
Qual:
Quant: 149.00 mg/dl
Source: previous donation
not specified not specified
Method: not specified
System: not specified not specified
Glycosylated hemoglobin (HbA1, HbA1c)
Qual:
Quant: 7.20 %
Source: previous donation
not specified not specified
Method: not specified
System: not specified not specified
Hepatitis B Virus surface Antigen (HBsAg)
Qual: negative
Quant:
Source: this donation
negative
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay)
System: Architect i 2000 sr Abbott
Disclaimer
  • All products are for research or manufacturing purposes only and are not for direct therapeutic or diagnostic use in human or animals.
  • Biospecimens should be treated as potentially infectious. Each specimen is intended for use only in by qualified professionals who will safely handle and dispose of the products they receive.
  • Import permit for biological substances must be present for purchase.
  • This sample is not for molecular genetic studies.
CBH170850
1 mL (€37.50)
Will be delivered in 16 to 20 Business Days (€180.00)

Human Serum - Glycosylated hemoglobin (HbA1, HbA1c) - E11.90

Donor:
Gender: Male Age: 57 Ethnic group: European/Caucasian
Diagnosed disease:
E11.90 - type 2 (not specified)
Medication:
ASA
Parameter:
Anti-Hepatitis C Virus (HCV) Anti-Human Immunodeficiency Virus-1/2 (HIV-1/2) Glycosylated hemoglobin (HbA1, HbA1c) Hepatitis B Virus surface Antigen (HBsAg)
Donor:
Gender:
Male
Age:
57 Years
Ethnic group:
European/Caucasian
BMI:
34 kg/m²
Weight:
110 kg
Height:
181 cm
Sample:
Matrix:
Serum
Condition:
perfect
Freeze-Thaw-Cycle:
0
Diseases:
  • diabetes mellitus [E11.90] - type 2 (not specified)
Medication:
  • ASA
  • Ezetrol (active agent: Ezetimib)
  • Omacor (active agent: omega-3 fatty acids)
  • Ramipril
  • no incretin mimetics
  • no insulin
  • pravastatin
Parameter Result Ref. / Cut-Off Measuring Information
Anti-Hepatitis C Virus (HCV)
Qual: negative
Quant:
Source: this donation
negative
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay)
System: Architect i 2000 sr Abbott
Anti-Human Immunodeficiency Virus-1/2 (HIV-1/2)
Qual: negative
Quant:
Source: this donation
negative
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay)
System: Architect i 2000 sr Abbott
Glycosylated hemoglobin (HbA1, HbA1c)
Qual:
Quant: 6.30 %
Source: previous donation
not specified not specified
Method: not specified
System: not specified not specified
Hepatitis B Virus surface Antigen (HBsAg)
Qual: negative
Quant:
Source: this donation
negative
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay)
System: Architect i 2000 sr Abbott
Disclaimer
  • All products are for research or manufacturing purposes only and are not for direct therapeutic or diagnostic use in human or animals.
  • Biospecimens should be treated as potentially infectious. Each specimen is intended for use only in by qualified professionals who will safely handle and dispose of the products they receive.
  • Import permit for biological substances must be present for purchase.
  • This sample is not for molecular genetic studies.
CBH197532
1 mL (€37.50)
Will be delivered in 16 to 20 Business Days (€180.00)

Human Serum - Blood glucose, Glycosylated hemoglobi... - E11.9

Donor:
Gender: Male Age: 73 Ethnic group: European/Caucasian
Diagnosed disease:
E11.9 - Type 2 diabetes mellitus without complications - type 2 (not specified)
Medication:
Lantus
Parameter:
Anti-Hepatitis C Virus (HCV) Anti-Human Immunodeficiency Virus-1/2 (HIV-1/2) Blood glucose Glycosylated hemoglobin (HbA1, HbA1c) Hepatitis B Virus surface Antigen (HBsAg)
Donor:
Gender:
Male
Age:
73 Years
Ethnic group:
European/Caucasian
BMI:
24 kg/m²
Weight:
71 kg
Height:
172 cm
Sample:
Matrix:
Serum
Condition:
perfect
Freeze-Thaw-Cycle:
0
Diseases:
  • diabetes mellitus [E11.9] - type 2 (not specified)
Medication:
  • Lantus
  • atorvastatin (specific information from donor: atorvastatin 20)
  • insulin
  • no incretin mimetics
Parameter Result Ref. / Cut-Off Measuring Information
Anti-Hepatitis C Virus (HCV)
Qual: negative
Quant:
Source: this donation
negative
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay)
System: Architect i 2000 sr Abbott
Anti-Human Immunodeficiency Virus-1/2 (HIV-1/2)
Qual: negative
Quant:
Source: this donation
negative
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay)
System: Architect i 2000 sr Abbott
Blood glucose
Qual:
Quant: < 6.5 %
Source: this donation
not specified not specified
Method: not specified
System: not specified not specified
Glycosylated hemoglobin (HbA1, HbA1c)
Qual:
Quant: 7.10 %
Source: previous donation
not specified not specified
Method: not specified
System: not specified not specified
Hepatitis B Virus surface Antigen (HBsAg)
Qual: negative
Quant:
Source: this donation
negative
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay)
System: Architect i 2000 sr Abbott
Disclaimer
  • All products are for research or manufacturing purposes only and are not for direct therapeutic or diagnostic use in human or animals.
  • Biospecimens should be treated as potentially infectious. Each specimen is intended for use only in by qualified professionals who will safely handle and dispose of the products they receive.
  • Import permit for biological substances must be present for purchase.
  • This sample is not for molecular genetic studies.
CBH165577
1 mL (€37.50)
Will be delivered in 16 to 20 Business Days (€180.00)

Human Serum - Blood glucose (postprandial), Glycosy... - E11.9

Donor:
Gender: Female Age: 60 Ethnic group: Not specified
Diagnosed disease:
E11.9 - Type 2 diabetes mellitus without complications - type 2 (not specified)
Medication:
metformin
Parameter:
Anti-Hepatitis C Virus (HCV) Anti-Human Immunodeficiency Virus-1/2 (HIV-1/2) Blood glucose (postprandial) Glycosylated hemoglobin (HbA1, HbA1c) Hepatitis B Virus surface Antigen (HBsAg)
Donor:
Gender:
Female
Age:
60 Years
Ethnic group:
Not specified
BMI:
30 kg/m²
Weight:
79 kg
Height:
162 cm
Sample:
Matrix:
Serum
Condition:
perfect
Freeze-Thaw-Cycle:
0
Diseases:
  • diabetes mellitus [E11.9] - type 2 (not specified)
Medication:
  • metformin
  • no incretin mimetics
  • no insulin
Parameter Result Ref. / Cut-Off Measuring Information
Anti-Hepatitis C Virus (HCV)
Qual: negative
Quant:
Source: this donation
negative
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay)
System: Architect i 2000 sr Abbott
Anti-Human Immunodeficiency Virus-1/2 (HIV-1/2)
Qual: negative
Quant:
Source: this donation
negative
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay)
System: Architect i 2000 sr Abbott
Blood glucose (postprandial)
Qual:
Quant: 107.00 mg/dl
Source: this donation
not specified not specified
Method: not specified
System: not specified not specified
Glycosylated hemoglobin (HbA1, HbA1c)
Qual:
Quant: 6.30 %
Source: previous donation
not specified not specified
Method: not specified
System: not specified not specified
Hepatitis B Virus surface Antigen (HBsAg)
Qual: negative
Quant:
Source: this donation
negative
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay)
System: Architect i 2000 sr Abbott
Disclaimer
  • All products are for research or manufacturing purposes only and are not for direct therapeutic or diagnostic use in human or animals.
  • Biospecimens should be treated as potentially infectious. Each specimen is intended for use only in by qualified professionals who will safely handle and dispose of the products they receive.
  • Import permit for biological substances must be present for purchase.
  • This sample is not for molecular genetic studies.
CBH165575
1 mL (€37.50)
Will be delivered in 16 to 20 Business Days (€180.00)

Human Serum - E11.9

Donor:
Gender: Male Age: 80 Ethnic group: European/Caucasian
Diagnosed disease:
E11.9 - Type 2 diabetes mellitus without complications - type 2 (not specified)
Medication:
Actrapid
Parameter:
Anti-Hepatitis C Virus (HCV) Anti-Human Immunodeficiency Virus-1/2 (HIV-1/2) Hepatitis B Virus surface Antigen (HBsAg)
Donor:
Gender:
Male
Age:
80 Years
Ethnic group:
European/Caucasian
BMI:
28 kg/m²
Weight:
98 kg
Height:
187 cm
Sample:
Matrix:
Serum
Condition:
perfect
Freeze-Thaw-Cycle:
0
Diseases:
  • diabetes mellitus [E11.9] - type 2 (not specified)
Medication:
  • Actrapid
  • Toujeo
  • insulin
  • metformin
  • no incretin mimetics
Parameter Result Ref. / Cut-Off Measuring Information
Anti-Hepatitis C Virus (HCV)
Qual: negative
Quant:
Source: this donation
negative
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay)
System: Architect i 2000 sr Abbott
Anti-Human Immunodeficiency Virus-1/2 (HIV-1/2)
Qual: negative
Quant:
Source: this donation
negative
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay)
System: Architect i 2000 sr Abbott
Hepatitis B Virus surface Antigen (HBsAg)
Qual: negative
Quant:
Source: this donation
negative
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay)
System: Architect i 2000 sr Abbott
Disclaimer
  • All products are for research or manufacturing purposes only and are not for direct therapeutic or diagnostic use in human or animals.
  • Biospecimens should be treated as potentially infectious. Each specimen is intended for use only in by qualified professionals who will safely handle and dispose of the products they receive.
  • Import permit for biological substances must be present for purchase.
  • This sample is not for molecular genetic studies.
CBH165634
1 mL (€37.50)
Will be delivered in 16 to 20 Business Days (€180.00)